Benefits Of Oxygen Saturation Targeting Study (BOOST-II) dataset
| Field | Value | Language |
| dc.contributor.author | Tarnow-Mordi, William | |
| dc.date.accessioned | 2023-06-27T06:32:13Z | |
| dc.date.available | 2023-06-27T06:32:13Z | |
| dc.date.issued | 2023-06-27 | |
| dc.identifier.uri | https://hdl.handle.net/2123/31397 | |
| dc.description.abstract | This dataset includes 1135 participants receiving either a lower (85 to 89%) or a higher (91 to 95%) oxygen-saturation range in 15 centres in Australia. Baseline data will include demographics, antenatal glucocorticoid treatment, method of delivery and temperature at admission to the neonatal unit. Clinical outcomes will include survival or disability status, language or cognitive score (based on the Bayley III Developmental Assessment) as well as health status including cerebral palsy with GMFCS ≥2, severe visual loss and severe hearing loss (based on the Health Status Assessment or Short Health Status Questionnaire) at corrected age of 2 years. | en_AU |
| dc.language.iso | en | en_AU |
| dc.rights | Other | en_AU |
| dc.title | Benefits Of Oxygen Saturation Targeting Study (BOOST-II) dataset | en_AU |
| dc.type | Dataset | en_AU |
| dc.identifier.doi | 10.25910/zkt9-bh42 | |
| dc.rights.other | Access can be requested via the Health Data Australia catalogue (https://researchdata.edu.au/health). A copy of the Data Sharing Guidelines can be found in https://rb.gy/bgrcq. For further information please contact the Health Studies Australian National Data Asset (HeSANDA) SHP-CTC node ([email protected]). | en_AU |
| usyd.faculty | SeS faculties schools::Faculty of Medicine and Health::NHMRC Clinical Trials Centre | en_AU |
| workflow.metadata.only | Yes | en_AU |
Associated file/s
Associated collections